Miguel Cosenza‐Contreras

Author

University of Freiburg ORCID

Also Known As

M. Cosenza-Contreras, Miguel Consenza-Contreras, Miguel Cosenza, Miguel Cosenza-Contreras, Miguel Cosenza‐Contreras

Publications

446

Citations

H-Index

Concepts

All Affiliations

University of Freiburg University Medical Center Freiburg German Cancer Research Center Heidelberg University Universidade Federal de Ouro Preto

About

Miguel Cosenza‐Contreras is an author at University of Freiburg specializing in tumor heterogeneity, health sciences, and genome editing.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Health Sciences	1	1	12
2	Medicine	1	1	12
3	Cell Biology	1	1	12
4	Pathology	1	1	12
5	Genome Editing	1	1	12

Miguel Cosenza‐Contreras

Publications

400

Citations

H-Index

Page 1

	Year	Citations
HIF-1α and HIF-2α differently regulate tumour development and inflammation of clear cell renal cell carcinoma in mice Rouven Hoefflin, Sabine Harlander, Silvia Schäfer, Nature Communications	2020	255
Proteome alterations in human autopsy tissues in relation to time after death Éva Kocsmár, Marlene Schmid, Miguel Cosenza‐Contreras, Cellular and Molecular Life Sciences	2023	26
Targeted and explorative profiling of kallikrein proteases and global proteome biology of pancreatic ductal adenocarcinoma, chronic pancreatitis, and normal pancreas highlights disease-specific proteome remodelling Janina Werner, Patrick Bernhard, Miguel Cosenza‐Contreras, Neoplasia	2023	25
TermineR: Extracting information on endogenous proteolytic processing from shotgun proteomics data Miguel Cosenza‐Contreras, Adrianna Seredynska, Daniel Vogele, PROTEOMICS	2024	16
Profiling the serum proteome during Schistosoma mansoni infection in the BALB/c mice: A focus on the altered lipid metabolism as a key modulator of host-parasite interactions Gustavo Gonçalves Silva, Lara Geralda Magela dos Santos Vieira, Miguel Cosenza‐Contreras, Frontiers in Immunology	2022	12
Proteome alterations during clonal isolation of established human pancreatic cancer cell lines Patrick Bernhard, Tobias Feilen, Manuel Rogg, Cellular and Molecular Life Sciences PathologyMonoclonal Cell PopulationCell ProliferationClonal IsolationCancer Biology	2022	12
The Schistosomiasis SpleenOME: Unveiling the Proteomic Landscape of Splenomegaly Using Label-Free Mass Spectrometry Miguel Cosenza‐Contreras, Renata Alves de Oliveira e Castro, Bruno Mattei, Frontiers in Immunology	2019	11
An adapted passive model of anti-MPO dependent crescentic glomerulonephritis reveals matrix dysregulation and is amenable to modulation by CXCR4 inhibition Chérine Abou Fayçal, André Oszwald, Tobias Feilen, Matrix Biology	2022	11
The serum proteome of VA-ECMO patients changes over time and allows differentiation of survivors and non-survivors: an observational study Patrick M. Siegel, Bálint András Barta, Lukas Orlean, Journal of Translational Medicine	2023	11
Proteometabolomics of initial and recurrent glioblastoma highlights an increased immune cell signature with altered lipid metabolism Miguel Cosenza‐Contreras, Agnes Schäfer, Justin Sing, Neuro-Oncology	2023	11

Page 1